Mouse APOBEC3 expression in NIH 3T3 cells mediates hypermutation of AKV murine leukemia virus

Stefano Boi1, Morgan E Ferrell1, Ming Zhao2

  • 1Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, Hamilton, MT 59840, USA.

Virology
|April 2, 2018
PubMed

Insights

Mouse APOBEC3 (mA3) restricts retroviral replication by causing G→A hypermutation. This study found significant endogenous mA3 in NIH 3T3 cells, explaining previously observed retroviral mutations and demonstrating mA3

Area of Science:

  • Virology
  • Molecular Biology
  • Immunology

Background:

  • Mouse APOBEC3 (mA3) is a cytidine deaminase involved in innate immunity against retroviruses.
  • Previous studies often assumed negligible endogenous mA3 in NIH 3T3 cells for retroviral research.
  • The role of endogenous mA3 in NIH 3T3 cells and its impact on retroviral mutation patterns remained unclear.

Purpose of the Study:

  • To investigate the presence and activity of endogenous mouse APOBEC3 (mA3) in NIH 3T3 cells.
  • To determine if endogenous mA3 mediates G→A hypermutation in retroviral transcripts.
  • To elucidate the mechanism behind the observed mutation distribution and mA3's role in restricting retroviral replication.

Main Methods:

  • Development of a monoclonal antibody specific for mouse APOBEC3 (mA3).
  • Detection of mA3 expression in NIH 3T3 cells using the developed antibody.
  • Analysis of AKV (a retrovirus) G→A hypermutation in viral transcripts.
  • Gene inactivation of mA3 to confirm its role in deamination.
  • Single-cell expression analysis of mA3 in NIH 3T3 cells.
  • Assessment of AKV replication in the presence of endogenous mA3.

Main Results:

  • Detectable levels of endogenous mouse APOBEC3 (mA3) were found in NIH 3T3 cells.
  • AKV retroviral DNA released from these cells exhibited significant G→A hypermutation.
  • Inactivation of the mA3 gene abolished the observed G→A hypermutation, confirming mA3's role.
  • Mutation distribution was non-uniform, with mutations concentrated in ~20% of transcripts.
  • Single-cell analysis revealed mA3 expression in only ~20% of NIH 3T3 cells, explaining the mutation pattern.
  • Endogenous mA3 effectively restricted AKV replication in NIH 3T3 cells.

Conclusions:

  • Endogenous mouse APOBEC3 (mA3) is present and active in NIH 3T3 cells.
  • mA3 mediates G→A hypermutation in AKV viral transcripts, restricting replication.
  • The restricted expression of mA3 in a subset of NIH 3T3 cells explains the observed mutation distribution.